Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/06/25
End: 05/31/27
Due: 05/31/28
Phase: N/A
Priority: Normal
Start: 05/16/25
End: 03/31/27
Due: 03/31/28
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE) | NCT06843239 | Zura Bio Inc | user2@example.com | None | 2025-02-06 | 2027-05-31 | 2028-05-31 | - | - | 2025-07-14 |
| Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense | NCT06993610 | Zura Bio Inc | user2@example.com | None | 2025-05-16 | 2027-03-31 | 2028-03-31 | - | - | 2025-07-14 |